Hematological alterations in erythrogram, leukogram, and thrombogram of rats with doxorubicin-induced renal toxicity

Year 2025, Volume: 10 Issue: 3, 200 - 204, 31.12.2025

Cemre Aydeğer , Mehmet Akif Ovalı , Mustafa Oguz Cumaoglu , Hilmi Nuhoğlu , Tahir Gezer , Mustafa Makav , Hüseyin Avni Eroğlu

https://doi.org/10.31797/vetbio.1786702

Abstract

Doxorubicin (DOX) is a widely used antineoplastic agent in cancer treatment; however, it has several drawbacks that can cause harmful effects on various organs, especially the kidneys. Nevertheless, it does not fully reveal the extent of DOX-induced tissue damage. Therefore, it is crucial to clarify the risks associated with DOX-mediated tissue injury. A total of 14 female Wistar Albino rats were divided into two equal groups: Control and Dox. The Dox group received a single dose of 20 mg/kg DOX. Kidney, liver, and blood samples were collected for further analysis. Hematoxylin-Eosin staining and biochemical tests were conducted to assess DOX-induced tissue damage. Our results showed that the Dox group experienced significant glomerular atrophy. Parameters such as RBC, HGB, HCT, and MCHC were also significantly higher compared to the Control group. No significant differences were observed in liver tissues between the groups. Inflammatory markers were also evaluated. NLR and SII scores showed statistically significant differences between the groups. Administration of DOX caused alterations in erythrocyte and leukocyte parameters, with notable changes in renal tissue characterized by glomerular atrophy.

Keywords

Doxorubicin , adverse effect , drug toxicity , acute renal injury

References

• Afsar, T., Razak, S., Almajwal, A., & Al-Disi, D. (2020). Doxorubicin-induced alterations in kidney functioning, oxidative stress, DNA damage, and renal tissue morphology; Improvement by Acacia hydaspica tannin-rich ethyl acetate fraction. Saudi Journal of Biological Sciences, 27(9), 2251. https://doi.org/10.1016/J.SJBS.2020.07.011
• Ajaykumar, C., & Ajaykumar, C. (2020). Overview on the Side Effects of Doxorubicin. Advances in Precision Medicine Oncology. https://doi.org/10.5772/INTECHOPEN.94896
• Bayır, H., Dixon, S. J., Tyurina, Y. Y., Kellum, J. A., & Kagan, V. E. (2023). Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nature Reviews Nephrology, 19(5), 315–336. https://doi.org/10.1038/S41581-023-00689-X
• Botros, S. R., Matouk, A. I., Amin, A., & Heeba, G. H. (2024). Comparative effects of incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of SIRT1/Nrf2/NF-κB/TNF-α signaling pathways. Frontiers in Pharmacology, 15, 1353029. https://doi.org/10.3389/FPHAR.2024.1353029
• Chen, X., Zhang, Y., Zhu, Z., Liu, H., Guo, H., Xiong, C., Xie, K., Zhang, X., & Su, S. (2016). Protective effect of berberine on doxorubicin-induced acute hepatorenal toxicity in rats. Molecular Medicine Reports, 13(5), 3953–3960. https://doi.org/10.3892/mmr.2016.5017
• Kaymak, E., Karabulut, D., Doğanyiğit, Z., Ceylan, T., Toluk, A., Özdamar, S., & Tuğrul Akın, A. (2021). Comparison of the Acute and Cumulative Dose Administrations in Doxorubicin-induced Hepatotoxicity via Evaluation of the Histopathological Changes and Inflammation in Rats. Gaziantep Islam Science and Technology University, 1(3), 73–81. https://doi.org/10.46871/eams.2020.10
• Kciuk, M., Gielecińska, A., Mujwar, S., Kołat, D., Kałuzińska-Kołat, Ż., Celik, I., & Kontek, R. (2023). Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity. Cells 2023, Vol. 12, Page 659, 12(4), 659. https://doi.org/10.3390/CELLS12040659
• Kim, Y. S., Sung, S. H., Tang, Y., Choi, E. J., Choi, Y. J., Hwang, Y. J., Park, P. J., & Kim, E. K. (2017). Protective Effect of Taurine on Mice with Doxorubicin-induced Acute Kidney Injury. Advances in Experimental Medicine and Biology, 975, 1191–1201. https://doi.org/10.1007/978-94-024-1079-2_95
• Prasanna, P. L., Renu, K., & Valsala Gopalakrishnan, A. (2020). New molecular and biochemical insights of doxorubicin-induced hepatotoxicity. Life Sciences, 250, 117599. https://doi.org/10.1016/J.LFS.2020.117599
• Pugazhendhi, A., Edison, T. N. J. I., Velmurugan, B. K., Jacob, J. A., & Karuppusamy, I. (2018). Toxicity of Doxorubicin (Dox) to different experimental organ systems. Life Sciences, 200, 26–30. https://doi.org/10.1016/J.LFS.2018.03.023
• Renu, K., Pureti, L. P., Vellingiri, B., & Valsala Gopalakrishnan, A. (2022). Toxic effects and molecular mechanism of doxorubicin on different organs–an update. Toxin Reviews, 41(2), 650–674. https://doi.org/10.1080/15569543.2021.1912099
• Sozmen, M., Erginsoy, S. D., Cenesis, S., & Devrim, A. K. (2005). The Protective Effect of Kefir and Vitamin C on Azoxymethane Induced Toxicity and Induction of Metallothionein in Mice. Scandinavian Journal of Laboratory Animal Science, 32(4), 211–220. https://doi.org/10.23675/SJLAS.V32I4.90
• Sritharan, S., & Sivalingam, N. (2021). A comprehensive review on time-tested anticancer drug doxorubicin. Life Sciences, 278, 119527. https://doi.org/10.1016/J.LFS.2021.119527
• Yagmurca, M., Yasar, Z., & Bas, O. (2015). Effects of quercetin on kidney injury induced by doxorubicin. Bratislavske Lekarske Listy, 116(8), 486–489. https://doi.org/10.4149/BLL_2015_092
• Zeng, X., Chen, X., Qin, H., Han, Y., Chen, X., Han, Z., & Zhao, W. (2020). Preventive effects of a natural anti-inflammatory agent Salvianolic acid A on acute kidney injury in mice. Food and Chemical Toxicology, 135, 110901. https://doi.org/10.1016/J.FCT.2019.110901
• Zordoky, B. N. M., Anwar-Mohamed, A., Aboutabl, M. E., & El-Kadi, A. O. S. (2010). Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats. Toxicology and Applied Pharmacology, 242(1), 38–46. https://doi.org/10.1016/j.taap.2009.09.012
• Zordoky, B. N. M., Anwar-Mohamed, A., Aboutabl, M. E., & El-Kadi, A. O. S. (2011). Acute Doxorubicin Toxicity Differentially Alters Cytochrome P450 Expression and Arachidonic Acid Metabolism in Rat Kidney and Liver. Drug Metabolism and Disposition, 39(8), 1440–1450. https://doi.org/10.1124/DMD.111.039123
• Zordoky, B. N. M., & El-Kadi, A. O. S. (2008). Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells. Vascular Pharmacology, 49(4–6), 166–172. https://doi.org/10.1016/j.vph.2008.07.004